FCM
TPTX

Farallon Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Farallon Capital Management’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,160,000
Closed -$87.3M – 324
2022
Q2 		$87.3M Buy
+1,160,000
New +$87.3M 0.47% 58
2021
Q3 		– Sell
-465,000
Closed -$36.3M – 320
2021
Q2 		$36.3M Sell
465,000
-35,000
-7% -$2.73M 0.15% 82
2021
Q1 		$47.3M Buy
+500,000
New +$47.3M 0.24% 74